跳至主要内容
临床试验/NCT01896388
NCT01896388已完成1 期

Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial

Chiba University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年1月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
The Impact of Event Scale-Revised Japanese Version : IES-R-J

研究概览

简要总结

Accumulating evidence suggests a key role of the N-methyl-D-aspartate (NMDA) receptor in the pathophysiology of post-traumatic stress disorder (PTSD). Recent studies suggest that the NMDA receptor antagonist ifenprodil tartrate may be a potential therapeutic drug for PTSD. The purpose of this study is to confirm whether ifenprodil tartrate is effective in the treatment of adolescents PTSD patients. If ifenprodil tartrate is effective in these patients, this study contributes to the development of novel therapeutic drugs for PTSD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
13 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Ifenprodil Tartrate

Active Comparator

Oral Administration of Ifenprodil Tartrate 40mg/day (20mg After breakfast, 20mg After supper)

干预措施: Ifenprodil Tartrate (Drug)

Placebo

Placebo Comparator

Oral Administration of Placebo (After breakfast, After supper)

干预措施: Placebo (Drug)

结局指标

主要结局

The Impact of Event Scale-Revised Japanese Version : IES-R-J

时间窗: Changes from baseline in IES-R-J at 4-weeks

Evidence includes retest reliability and internal consistency of the IES-R-J. Posttraumatic stress disorder (PTSD) and partial PTSD cases indicated significantly higher scores than non-PTSD cases. The IES-R-J can be a useful self-rating diagnostic instrument particularly for survivors with PTSD symptoms as a clinical concern (PTSD + partial PTSD) by using a 24/25 cutoff in total score. The IES-R-J can be used as a validated instrument in future international comparative research.

次要结局

  • Trauma Symptom Checklist for Children Japanese Version : TSCC-J(Changes from baseline in TSCC-J at 4-weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tsuyoshi Sasaki

Tsuyoshi Sasaki, Clinical Associate Professor

Chiba University

研究点 (1)

Loading locations...

相似试验